+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Implantable Drug Eluting Stent Market - Global Forecast 2026-2032- Product Image
Implantable Drug Eluting Stent Market - Global Forecast 2026-2032- Product Image
Sale

Implantable Drug Eluting Stent Market - Global Forecast 2026-2032

  • Report

  • 187 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6124232
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Implantable Drug Eluting Stent Market is projected to reach USD 4.05 Billion in 2026. It is expected to continue growing at a CAGR of 8.53%, reaching USD 6.69 Billion by 2032.

Implantable Drug-Eluting Stents: Executive Overview

Implantable drug-eluting stents combine a vascular scaffold with localized drug delivery to help limit restenosis after percutaneous coronary intervention. Their clinical value depends on appropriate patient selection, lesion preparation, stent deployment, antiplatelet management, and follow-up. This executive summary reviews the sector through technology, regulation, healthcare-system, and geographic lenses without presenting market estimates, market shares, forecasts, or company-specific claims.

Clinical and Regulatory Shifts Reshaping Stent Adoption

The landscape is shifting toward thinner struts, improved deliverability, durable or bioabsorbable polymer systems, and drug platforms designed to balance suppression of neointimal growth with vessel healing. Evidence generation increasingly emphasizes complex lesions, diabetes, small vessels, long lesions, bifurcations, and high-bleeding-risk patients rather than only straightforward coronary disease. Regulatory expectations also continue to focus on biocompatibility, mechanical integrity, drug-release consistency, thrombosis risk, post-market surveillance, and clinically meaningful comparative outcomes.

Artificial Intelligence Strengthens Planning, Execution, and Follow-Up

Artificial intelligence is increasingly relevant across the stent pathway. Imaging algorithms can support lesion characterization, vessel sizing, calcium assessment, and procedural planning, while decision-support tools may help integrate angiography, intravascular imaging, clinical history, and laboratory data. After implantation, analytics can assist risk stratification and identify patients needing review. However, safe deployment requires representative validation, transparent performance measures, cybersecurity controls, clinician oversight, and clear accountability when algorithmic recommendations conflict with clinical judgment.

Regional Insights Across Six Diverse Care Environments

North America is characterized by advanced interventional infrastructure, extensive clinical evidence requirements, and attention to value-based care and bleeding-risk management. Europe combines sophisticated catheterization services with differing national reimbursement and assessment pathways. Asia-Pacific includes highly capable urban centers alongside substantial access variation, with Japan, China, South Korea, India, and Australia each operating under distinct regulatory and clinical systems. Latin America is shaped by uneven procurement capacity, imported-device dependence in some settings, and growing demand for cardiovascular intervention. The Middle East is investing in tertiary cardiac services, while access and specialist distribution vary across Gulf and non-Gulf systems. Africa faces pronounced differences in diagnostic capacity, referral networks, affordability, and availability of complex PCI services.

Group-Level Dynamics Across ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN countries show strong variation in public and private cardiac-care capacity, regulatory maturity, and dependence on referral centers. BRICS members span large, heterogeneous populations and are prioritizing domestic manufacturing, clinical infrastructure, and broader access while facing different approval and reimbursement conditions. The European Union benefits from coordinated regulatory structures but retains national differences in procurement and coverage. G7 systems generally emphasize evidence quality, patient safety, health-technology assessment, and sustainability. GCC countries are strengthening specialist hospital capacity and cross-border care networks. NATO membership is not a healthcare market category, but its countries include many systems with established cardiovascular infrastructure, regulated procurement, and resilience considerations for medical-device supply chains.

Country Perspectives: Priorities Differ Across Fifteen Health Systems

Australia emphasizes evidence-based public coverage and specialist referral pathways. Brazil combines advanced private-sector intervention with unequal regional access. Canada operates through publicly financed provincial systems and centralized assessment processes. China is expanding cardiovascular capacity while emphasizing regulatory oversight and domestic supply resilience. France, Germany, Italy, Spain, and the United Kingdom have mature interventional services but differ in reimbursement, procurement, and health-technology assessment. India has a broad mix of high-end private hospitals and resource-constrained public facilities. Japan places strong weight on clinical evidence, procedural quality, and an aging population’s needs. Mexico continues to address unequal access between major urban centers and other areas. Russia’s cardiovascular services and procurement environment are shaped by national policy and supply-chain constraints. South Korea combines advanced hospital infrastructure with rigorous regulatory and reimbursement considerations. The United States has extensive interventional capacity, detailed evidence requirements, and growing attention to total episode value and high-bleeding-risk populations.

Actions for Leaders: Align Evidence, Access, and Procedural Quality

Industry leaders should prioritize clinically differentiated designs supported by transparent evidence in relevant high-risk populations, while maintaining rigorous biocompatibility, mechanical, and drug-release controls. Partnerships with hospitals and clinicians can improve training in imaging, lesion preparation, deployment, and antiplatelet decision-making. Geographic strategies should be tailored to local approval, reimbursement, procurement, and referral realities rather than treated as uniform regional plans. Organizations should also establish post-market surveillance, real-world data governance, cybersecurity safeguards for connected analytics, and responsible AI validation. Finally, supply-chain diversification and sustainability planning can improve resilience without compromising product quality or patient safety.

Methodology: Evidence-Based Synthesis Without Market Forecasting

This executive summary uses a structured qualitative synthesis of established clinical, regulatory, technology, and healthcare-system considerations relevant to implantable drug-eluting stents. The framework compares product attributes, procedural requirements, evidence expectations, access conditions, and implementation issues across the specified regions, groups, and countries. It deliberately excludes market estimates, market sizing, market shares, forecasts, and company-specific analysis. Interpretation should be supplemented with current clinical guidelines, regulatory publications, peer-reviewed studies, reimbursement decisions, and local hospital protocols before strategic or clinical decisions are made.

Conclusion: Durable Value Depends on Evidence and Responsible Implementation

Implantable drug-eluting stents remain part of a broader interventional-care pathway in which device design, imaging, operator skill, pharmacotherapy, follow-up, and health-system access jointly determine outcomes. The most durable progress will come from clinically credible innovation paired with disciplined regulatory compliance, equitable training, reliable supply, and appropriate use of digital tools. Regional and country differences make adaptable implementation essential, while continued evidence generation is necessary to ensure that advances translate into safer, more effective care.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Implantable Drug Eluting Stent Market, by Stent Generation
7.1. Introduction
7.2. First Generation
7.3. Second Generation
7.4. Third Generation
8. Implantable Drug Eluting Stent Market, by Polymer Coating
8.1. Introduction
8.2. Bioabsorbable Polymer
8.2.1. Poly-L-Lactic Acid
8.2.2. Polyglycolic Acid
8.3. Durable Polymer
8.4. Polymer Free
9. Implantable Drug Eluting Stent Market, by Drug Coating
9.1. Introduction
9.2. Everolimus
9.3. Paclitaxel
9.4. Sirolimus
9.5. Zotarolimus
10. Implantable Drug Eluting Stent Market, by End User
10.1. Introduction
10.2. Ambulatory Surgery Centers
10.3. Cardiac Catheterization Laboratories
10.4. Hospitals
10.4.1. Private Hospitals
10.4.2. Public Hospitals
11. Implantable Drug Eluting Stent Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Implantable Drug Eluting Stent Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Implantable Drug Eluting Stent Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Abbott Laboratories
15.2. Alvimedica Medical Technologies Inc.
15.3. B. Braun Melsungen AG
15.4. Balton Sp. z o.o.
15.5. Biosensors International Group, Ltd.
15.6. BIOTRONIK SE & Co. KG
15.7. Boston Scientific Corporation
15.8. Concept Medical, Inc.
15.9. Cook Medical Incorporated
15.10. Elixir Medical Corporation
15.11. Eucatech AG
15.12. Eurocor GmbH
15.13. iVascular S.L.U.
15.14. Lepu Medical Technology (Beijing) Co., Ltd.
15.15. Medinol Ltd.
15.16. Medtronic plc
15.17. Meril Life Sciences Pvt. Ltd.
15.18. OrbusNeich Medical Group
15.19. Sahajanand Medical Technologies Ltd.
15.20. Terumo Corporation
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Implantable Drug Eluting Stent Market, Years Considered for the Study
FIGURE 2. Global Implantable Drug Eluting Stent Market, Research Design
FIGURE 3. Global Implantable Drug Eluting Stent Market, Research Framework
FIGURE 4. Global Implantable Drug Eluting Stent Market, Data Triangulation
FIGURE 5. Global Implantable Drug Eluting Stent Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Implantable Drug Eluting Stent Market Size, by Stent Generation, 2025 vs 2032 (%)
FIGURE 7. Global Implantable Drug Eluting Stent Market Size, by Stent Generation, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Implantable Drug Eluting Stent Market Size, by Polymer Coating, 2025 vs 2032 (%)
FIGURE 9. Global Implantable Drug Eluting Stent Market Size, by Polymer Coating, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Implantable Drug Eluting Stent Market Size, by Drug Coating, 2025 vs 2032 (%)
FIGURE 11. Global Implantable Drug Eluting Stent Market Size, by Drug Coating, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Implantable Drug Eluting Stent Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Implantable Drug Eluting Stent Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Implantable Drug Eluting Stent Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Implantable Drug Eluting Stent Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Implantable Drug Eluting Stent Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Implantable Drug Eluting Stent Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Implantable Drug Eluting Stent Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Implantable Drug Eluting Stent Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Implantable Drug Eluting Stent Market Segmentation & Coverage
TABLE 2. Global Implantable Drug Eluting Stent Market Size, 2017-2032 (USD Million)
TABLE 3. Global Implantable Drug Eluting Stent Market Size, by Stent Generation, 2017-2032 (USD Million)
TABLE 4. Global First Generation Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global First Generation Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global First Generation Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Second Generation Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Second Generation Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Second Generation Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Third Generation Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Third Generation Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Third Generation Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Implantable Drug Eluting Stent Market Size, by Polymer Coating, 2017-2032 (USD Million)
TABLE 14. Global Bioabsorbable Polymer Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Bioabsorbable Polymer Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Bioabsorbable Polymer Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Poly-L-Lactic Acid Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Poly-L-Lactic Acid Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Poly-L-Lactic Acid Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Polyglycolic Acid Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Polyglycolic Acid Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Polyglycolic Acid Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Durable Polymer Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Durable Polymer Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Durable Polymer Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Polymer Free Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Polymer Free Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Polymer Free Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Implantable Drug Eluting Stent Market Size, by Drug Coating, 2017-2032 (USD Million)
TABLE 30. Global Everolimus Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Everolimus Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Everolimus Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Paclitaxel Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Paclitaxel Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Paclitaxel Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Sirolimus Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Sirolimus Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Sirolimus Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Zotarolimus Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Zotarolimus Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Zotarolimus Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Implantable Drug Eluting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 43. Global Ambulatory Surgery Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Ambulatory Surgery Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Ambulatory Surgery Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Cardiac Catheterization Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Cardiac Catheterization Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Cardiac Catheterization Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Private Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Private Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Private Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Public Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Public Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Public Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Implantable Drug Eluting Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Asia-Pacific Implantable Drug Eluting Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Asia-Pacific Implantable Drug Eluting Stent Market Size, by Stent Generation, 2017-2032 (USD Million)
TABLE 61. Asia-Pacific Implantable Drug Eluting Stent Market Size, by Polymer Coating, 2017-2032 (USD Million)
TABLE 62. Asia-Pacific Implantable Drug Eluting Stent Market Size, by Bioabsorbable Polymer, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Implantable Drug Eluting Stent Market Size, by Drug Coating, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific Implantable Drug Eluting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific Implantable Drug Eluting Stent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 66. North America Implantable Drug Eluting Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. North America Implantable Drug Eluting Stent Market Size, by Stent Generation, 2017-2032 (USD Million)
TABLE 68. North America Implantable Drug Eluting Stent Market Size, by Polymer Coating, 2017-2032 (USD Million)
TABLE 69. North America Implantable Drug Eluting Stent Market Size, by Bioabsorbable Polymer, 2017-2032 (USD Million)
TABLE 70. North America Implantable Drug Eluting Stent Market Size, by Drug Coating, 2017-2032 (USD Million)
TABLE 71. North America Implantable Drug Eluting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 72. North America Implantable Drug Eluting Stent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 73. Latin America Implantable Drug Eluting Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Latin America Implantable Drug Eluting Stent Market Size, by Stent Generation, 2017-2032 (USD Million)
TABLE 75. Latin America Implantable Drug Eluting Stent Market Size, by Polymer Coating, 2017-2032 (USD Million)
TABLE 76. Latin America Implantable Drug Eluting Stent Market Size, by Bioabsorbable Polymer, 2017-2032 (USD Million)
TABLE 77. Latin America Implantable Drug Eluting Stent Market Size, by Drug Coating, 2017-2032 (USD Million)
TABLE 78. Latin America Implantable Drug Eluting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 79. Latin America Implantable Drug Eluting Stent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 80. Europe Implantable Drug Eluting Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Europe Implantable Drug Eluting Stent Market Size, by Stent Generation, 2017-2032 (USD Million)
TABLE 82. Europe Implantable Drug Eluting Stent Market Size, by Polymer Coating, 2017-2032 (USD Million)
TABLE 83. Europe Implantable Drug Eluting Stent Market Size, by Bioabsorbable Polymer, 2017-2032 (USD Million)
TABLE 84. Europe Implantable Drug Eluting Stent Market Size, by Drug Coating, 2017-2032 (USD Million)
TABLE 85. Europe Implantable Drug Eluting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 86. Europe Implantable Drug Eluting Stent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 87. Middle East Implantable Drug Eluting Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Middle East Implantable Drug Eluting Stent Market Size, by Stent Generation, 2017-2032 (USD Million)
TABLE 89. Middle East Implantable Drug Eluting Stent Market Size, by Polymer Coating, 2017-2032 (USD Million)
TABLE 90. Middle East Implantable Drug Eluting Stent Market Size, by Bioabsorbable Polymer, 2017-2032 (USD Million)
TABLE 91. Middle East Implantable Drug Eluting Stent Market Size, by Drug Coating, 2017-2032 (USD Million)
TABLE 92. Middle East Implantable Drug Eluting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 93. Middle East Implantable Drug Eluting Stent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 94. Africa Implantable Drug Eluting Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Africa Implantable Drug Eluting Stent Market Size, by Stent Generation, 2017-2032 (USD Million)
TABLE 96. Africa Implantable Drug Eluting Stent Market Size, by Polymer Coating, 2017-2032 (USD Million)
TABLE 97. Africa Implantable Drug Eluting Stent Market Size, by Bioabsorbable Polymer, 2017-2032 (USD Million)
TABLE 98. Africa Implantable Drug Eluting Stent Market Size, by Drug Coating, 2017-2032 (USD Million)
TABLE 99. Africa Implantable Drug Eluting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 100. Africa Implantable Drug Eluting Stent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 101. Global Implantable Drug Eluting Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. ASEAN Implantable Drug Eluting Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. ASEAN Implantable Drug Eluting Stent Market Size, by Stent Generation, 2017-2032 (USD Million)
TABLE 104. ASEAN Implantable Drug Eluting Stent Market Size, by Polymer Coating, 2017-2032 (USD Million)
TABLE 105. ASEAN Implantable Drug Eluting Stent Market Size, by Bioabsorbable Polymer, 2017-2032 (USD Million)
TABLE 106. ASEAN Implantable Drug Eluting Stent Market Size, by Drug Coating, 2017-2032 (USD Million)
TABLE 107. ASEAN Implantable Drug Eluting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 108. ASEAN Implantable Drug Eluting Stent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 109. GCC Implantable Drug Eluting Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. GCC Implantable Drug Eluting Stent Market Size, by Stent Generation, 2017-2032 (USD Million)
TABLE 111. GCC Implantable Drug Eluting Stent Market Size, by Polymer Coating, 2017-2032 (USD Million)
TABLE 112. GCC Implantable Drug Eluting Stent Market Size, by Bioabsorbable Polymer, 2017-2032 (USD Million)
TABLE 113. GCC Implantable Drug Eluting Stent Market Size, by Drug Coating, 2017-2032 (USD Million)
TABLE 114. GCC Implantable Drug Eluting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 115. GCC Implantable Drug Eluting Stent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 116. European Union Implantable Drug Eluting Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. European Union Implantable Drug Eluting Stent Market Size, by Stent Generation, 2017-2032 (USD Million)
TABLE 118. European Union Implantable Drug Eluting Stent Market Size, by Polymer Coating, 2017-2032 (USD Million)
TABLE 119. European Union Implantable Drug Eluting Stent Market Size, by Bioabsorbable Polymer, 2017-2032 (USD Million)
TABLE 120. European Union Implantable Drug Eluting Stent Market Size, by Drug Coating, 2017-2032 (USD Million)
TABLE 121. European Union Implantable Drug Eluting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 122. European Union Implantable Drug Eluting Stent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 123. BRICS Implantable Drug Eluting Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. BRICS Implantable Drug Eluting Stent Market Size, by Stent Generation, 2017-2032 (USD Million)
TABLE 125. BRICS Implantable Drug Eluting Stent Market Size, by Polymer Coating, 2017-2032 (USD Million)
TABLE 126. BRICS Implantable Drug Eluting Stent Market Size, by Bioabsorbable Polymer, 2017-2032 (USD Million)
TABLE 127. BRICS Implantable Drug Eluting Stent Market Size, by Drug Coating, 2017-2032 (USD Million)
TABLE 128. BRICS Implantable Drug Eluting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 129. BRICS Implantable Drug Eluting Stent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 130. G7 Implantable Drug Eluting Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. G7 Implantable Drug Eluting Stent Market Size, by Stent Generation, 2017-2032 (USD Million)
TABLE 132. G7 Implantable Drug Eluting Stent Market Size, by Polymer Coating, 2017-2032 (USD Million)
TABLE 133. G7 Implantable Drug Eluting Stent Market Size, by Bioabsorbable Polymer, 2017-2032 (USD Million)
TABLE 134. G7 Implantable Drug Eluting Stent Market Size, by Drug Coating, 2017-2032 (USD Million)
TABLE 135. G7 Implantable Drug Eluting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 136. G7 Implantable Drug Eluting Stent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 137. NATO Implantable Drug Eluting Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. NATO Implantable Drug Eluting Stent Market Size, by Stent Generation, 2017-2032 (USD Million)
TABLE 139. NATO Implantable Drug Eluting Stent Market Size, by Polymer Coating, 2017-2032 (USD Million)
TABLE 140. NATO Implantable Drug Eluting Stent Market Size, by Bioabsorbable Polymer, 2017-2032 (USD Million)
TABLE 141. NATO Implantable Drug Eluting Stent Market Size, by Drug Coating, 2017-2032 (USD Million)
TABLE 142. NATO Implantable Drug Eluting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 143. NATO Implantable Drug Eluting Stent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 144. Global Implantable Drug Eluting Stent Market Size, by Country, 2017-2032 (USD Million)
TABLE 145. United States Implantable Drug Eluting Stent Market Size, 2017-2032 (USD Million)
TABLE 146. United States Implantable Drug Eluting Stent Market Size, by Stent Generation, 2017-2032 (USD Million)
TABLE 147. United States Implantable Drug Eluting Stent Market Size, by Polymer Coating, 2017-2032 (USD Million)
TABLE 148. United States Implantable Drug Eluting Stent Market Size, by Bioabsorbable Polymer, 2017-2032 (USD Million)
TABLE 149. United States Implantable Drug Eluting Stent Market Size, by Drug Coating, 2017-2032 (USD Million)
TABLE 150. United States Implantable Drug Eluting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 151. United States Implantable Drug Eluting Stent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 152. Canada Implantable Drug Eluting Stent Market Size, 2017-2032 (USD Million)
TABLE 153. Canada Implantable Drug Eluting Stent Market Size, by Stent Generation, 2017-2032 (USD Million)
TABLE 154. Canada Implantable Drug Eluting Stent Market Size, by Polymer Coating, 2017-2032 (USD Million)
TABLE 155. Canada Implantable Drug Eluting Stent Market Size, by Bioabsorbable Polymer, 2017-2032 (USD Million)
TABLE 156. Canada Implantable Drug Eluting Stent Market Size, by Drug Coating, 2017-2032 (USD Million)
TABLE 157. Canada Implantable Drug Eluting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 158. Canada Implantable Drug Eluting Stent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 159. Mexico Implantable Drug Eluting Stent Market Size, 2017-2032 (USD Million)
TABLE 160. Mexico Implantable Drug Eluting Stent Market Size, by Stent Generation, 2017-2032 (USD Million)
TABLE 161. Mexico Implantable Drug Eluting Stent Market Size, by Polymer Coating, 2017-2032 (USD Million)
TABLE 162. Mexico Implantable Drug Eluting Stent Market Size, by Bioabsorbable Polymer, 2017-2032 (USD Million)
TABLE 163. Mexico Implantable Drug Eluting Stent Market Size, by Drug Coating, 2017-2032 (USD Million)
TABLE 164. Mexico Implantable Drug Eluting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 165. Mexico Implantable Drug Eluting Stent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 166. Brazil Implantable Drug Eluting Stent Market Size, 2017-2032 (USD Million)
TABLE 167. Brazil Implantable Drug Eluting Stent Market Size, by Stent Generation, 2017-2032 (USD Million)
TABLE 168. Brazil Implantable Drug Eluting Stent Market Size, by Polymer Coating, 2017-2032 (USD Million)
TABLE 169. Brazil Implantable Drug Eluting Stent Market Size, by Bioabsorbable Polymer, 2017-2032 (USD Million)
TABLE 170. Brazil Implantable Drug Eluting Stent Market Size, by Drug Coating, 2017-2032 (USD Million)
TABLE 171. Brazil Implantable Drug Eluting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 172. Brazil Implantable Drug Eluting Stent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 173. United Kingdom Implantable Drug Eluting Stent Market Size, 2017-2032 (USD Million)
TABLE 174. United Kingdom Implantable Drug Eluting Stent Market Size, by Stent Generation, 2017-2032 (USD Million)
TABLE 175. United Kingdom Implantable Drug Eluting Stent Market Size, by Polymer Coating, 2017-2032 (USD Million)
TABLE 176. United Kingdom Implantable Drug Eluting Stent Market Size, by Bioabsorbable Polymer, 2017-2032 (USD Million)
TABLE 177. United Kingdom Implantable Drug Eluting Stent Market Size, by Drug Coating, 2017-2032 (USD Million)
TABLE 178. United Kingdom Implantable Drug Eluting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 179. United Kingdom Implantable Drug Eluting Stent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 180. Germany Implantable Drug Eluting Stent Market Size, 2017-2032 (USD Million)
TABLE 181. Germany Implantable Drug Eluting Stent Market Size, by Stent Generation, 2017-2032 (USD Million)
TABLE 182. Germany Implantable Drug Eluting Stent Market Size, by Polymer Coating, 2017-2032 (USD Million)
TABLE 183. Germany Implantable Drug Eluting Stent Market Size, by Bioabsorbable Polymer, 2017-2032 (USD Million)
TABLE 184. Germany Implantable Drug Eluting Stent Market Size, by Drug Coating, 2017-2032 (USD Million)
TABLE 185. Germany Implantable Drug Eluting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 186. Germany Implantable Drug Eluting Stent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 187. France Implantable Drug Eluting Stent Market Size, 2017-2032 (USD Million)
TABLE 188. France Implantable Drug Eluting Stent Market Size, by Stent Generation, 2017-2032 (USD Million)
TABLE 189. France Implantable Drug Eluting Stent Market Size, by Polymer Coating, 2017-2032 (USD Million)
TABLE 190. France Implantable Drug Eluting Stent Market Size, by Bioabsorbable Polymer, 2017-2032 (USD Million)
TABLE 191. France Implantable Drug Eluting Stent Market Size, by Drug Coating, 2017-2032 (USD Million)
TABLE 192. France Implantable Drug Eluting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 193. France Implantable Drug Eluting Stent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 194. Russia Implantable Drug Eluting Stent Market Size, 2017-2032 (USD Million)
TABLE 195. Russia Implantable Drug Eluting Stent Market Size, by Stent Generation, 2017-2032 (USD Million)
TABLE 196. Russia Implantable Drug Eluting Stent Market Size, by Polymer Coating, 2017-2032 (USD Million)
TABLE 197. Russia Implantable Drug Eluting Stent Market Size, by Bioabsorbable Polymer, 2017-2032 (USD Million)
TABLE 198. Russia Implantable Drug Eluting Stent Market Size, by Drug Coating, 2017-2032 (USD Million)
TABLE 199. Russia Implantable Drug Eluting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 200. Russia Implantable Drug Eluting Stent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 201. Italy Implantable Drug Eluting Stent Market Size, 2017-2032 (USD Million)
TABLE 202. Italy Implantable Drug Eluting Stent Market Size, by Stent Generation, 2017-2032 (USD Million)
TABLE 203. Italy Implantable Drug Eluting Stent Market Size, by Polymer Coating, 2017-2032 (USD Million)
TABLE 204. Italy Implantable Drug Eluting Stent Market Size, by Bioabsorbable Polymer, 2017-2032 (USD Million)
TABLE 205. Italy Implantable Drug Eluting Stent Market Size, by Drug Coating, 2017-2032 (USD Million)
TABLE 206. Italy Implantable Drug Eluting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 207. Italy Implantable Drug Eluting Stent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 208. Spain Implantable Drug Eluting Stent Market Size, 2017-2032 (USD Million)
TABLE 209. Spain Implantable Drug Eluting Stent Market Size, by Stent Generation, 2017-2032 (USD Million)
TABLE 210. Spain Implantable Drug Eluting Stent Market Size, by Polymer Coating, 2017-2032 (USD Million)
TABLE 211. Spain Implantable Drug Eluting Stent Market Size, by Bioabsorbable Polymer, 2017-2032 (USD Million)
TABLE 212. Spain Implantable Drug Eluting Stent Market Size, by Drug Coating, 2017-2032 (USD Million)
TABLE 213. Spain Implantable Drug Eluting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 214. Spain Implantable Drug Eluting Stent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 215. China Implantable Drug Eluting Stent Market Size, 2017-2032 (USD Million)
TABLE 216. China Implantable Drug Eluting Stent Market Size, by Stent Generation, 2017-2032 (USD Million)
TABLE 217. China Implantable Drug Eluting Stent Market Size, by Polymer Coating, 2017-2032 (USD Million)
TABLE 218. China Implantable Drug Eluting Stent Market Size, by Bioabsorbable Polymer, 2017-2032 (USD Million)
TABLE 219. China Implantable Drug Eluting Stent Market Size, by Drug Coating, 2017-2032 (USD Million)
TABLE 220. China Implantable Drug Eluting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 221. China Implantable Drug Eluting Stent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 222. India Implantable Drug Eluting Stent Market Size, 2017-2032 (USD Million)
TABLE 223. India Implantable Drug Eluting Stent Market Size, by Stent Generation, 2017-2032 (USD Million)
TABLE 224. India Implantable Drug Eluting Stent Market Size, by Polymer Coating, 2017-2032 (USD Million)
TABLE 225. India Implantable Drug Eluting Stent Market Size, by Bioabsorbable Polymer, 2017-2032 (USD Million)
TABLE 226. India Implantable Drug Eluting Stent Market Size, by Drug Coating, 2017-2032 (USD Million)
TABLE 227. India Implantable Drug Eluting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 228. India Implantable Drug Eluting Stent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 229. Japan Implantable Drug Eluting Stent Market Size, 2017-2032 (USD Million)
TABLE 230. Japan Implantable Drug Eluting Stent Market Size, by Stent Generation, 2017-2032 (USD Million)
TABLE 231. Japan Implantable Drug Eluting Stent Market Size, by Polymer Coating, 2017-2032 (USD Million)
TABLE 232. Japan Implantable Drug Eluting Stent Market Size, by Bioabsorbable Polymer, 2017-2032 (USD Million)
TABLE 233. Japan Implantable Drug Eluting Stent Market Size, by Drug Coating, 2017-2032 (USD Million)
TABLE 234. Japan Implantable Drug Eluting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 235. Japan Implantable Drug Eluting Stent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 236. Australia Implantable Drug Eluting Stent Market Size, 2017-2032 (USD Million)
TABLE 237. Australia Implantable Drug Eluting Stent Market Size, by Stent Generation, 2017-2032 (USD Million)
TABLE 238. Australia Implantable Drug Eluting Stent Market Size, by Polymer Coating, 2017-2032 (USD Million)
TABLE 239. Australia Implantable Drug Eluting Stent Market Size, by Bioabsorbable Polymer, 2017-2032 (USD Million)
TABLE 240. Australia Implantable Drug Eluting Stent Market Size, by Drug Coating, 2017-2032 (USD Million)
TABLE 241. Australia Implantable Drug Eluting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 242. Australia Implantable Drug Eluting Stent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 243. South Korea Implantable Drug Eluting Stent Market Size, 2017-2032 (USD Million)
TABLE 244. South Korea Implantable Drug Eluting Stent Market Size, by Stent Generation, 2017-2032 (USD Million)
TABLE 245. South Korea Implantable Drug Eluting Stent Market Size, by Polymer Coating, 2017-2032 (USD Million)
TABLE 246. South Korea Implantable Drug Eluting Stent Market Size, by Bioabsorbable Polymer, 2017-2032 (USD Million)
TABLE 247. South Korea Implantable Drug Eluting Stent Market Size, by Drug Coating, 2017-2032 (USD Million)
TABLE 248. South Korea Implantable Drug Eluting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 249. South Korea Implantable Drug Eluting Stent Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 250. Global Implantable Drug Eluting Stent Market Share, by Key Player, 2025
TABLE 251. Global Implantable Drug Eluting Stent Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Alvimedica Medical Technologies Inc.
  • B. Braun Melsungen AG
  • Balton Sp. z o.o.
  • Biosensors International Group, Ltd.
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Concept Medical, Inc.
  • Cook Medical Incorporated
  • Elixir Medical Corporation
  • Eucatech AG
  • Eurocor GmbH
  • iVascular S.L.U.
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Medinol Ltd.
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • OrbusNeich Medical Group
  • Sahajanand Medical Technologies Ltd.
  • Terumo Corporation

Related Topics

Related Reports

Implantable Coronary Drug Eluting Stent Market - Global Forecast 2026-2032 - Product Image

Implantable Coronary Drug Eluting Stent Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Implantable Drug Eluting Balloon Market - Global Forecast 2026-2032 - Product Image

Implantable Drug Eluting Balloon Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Drug-Eluting Stents Market Report by Coating, Drug, Stent Platform, Generation, Application, End User, and Region ?2026-2034? - Product Image

Drug-Eluting Stents Market Report by Coating, Drug, Stent Platform, Generation, Application, End User, and Region ?2026-2034?

  • Report
  • 149 Pages
  • Global
From
Drug-Eluting Stents - Global Strategic Business Report - Product Image

Drug-Eluting Stents - Global Strategic Business Report

  • Report
  • 465 Pages
  • Global
From
Drug Eluting Stent Market Size, Share & Trends Analysis Report by Type of Coating, End Use, Region, and Growth Forecasts, 2026-2033 - Product Image

Drug Eluting Stent Market Size, Share & Trends Analysis Report by Type of Coating, End Use, Region, and Growth Forecasts, 2026-2033

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.